Lower Accuracy Alzheimer Disease Blood Tests Will Never Be "Ready for Prime Time"

Editorial

. 2024 Apr 23;102(8):e209295.

doi: 10.1212/WNL.0000000000209295. Epub 2024 Mar 25.

Affiliations

Editorial

Rachel F Buckley et al. Neurology. 2024.

. 2024 Apr 23;102(8):e209295.

doi: 10.1212/WNL.0000000000209295. Epub 2024 Mar 25.

¹ From the Massachusetts General Hospital (R.F.B.); Washington University School of Medicine (S.E.S.).

No abstract available

Similar articles

A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?
Galasko DR, Grill JD, Lingler JH, Heidebrink JL; Symptomatic Subcommittee of the Advisory Group on Risk Evidence Education for Dementia (AGREEDementia). Galasko DR, et al. J Alzheimers Dis. 2022;90(3):963-966. doi: 10.3233/JAD-215490. J Alzheimers Dis. 2022. PMID: 35147543
Alzheimer Blood Test Using Tau Biomarker Is in Development.
Abbasi J. Abbasi J. JAMA. 2020 Apr 14;323(14):1336. doi: 10.1001/jama.2020.4542. JAMA. 2020. PMID: 32286632 No abstract available.
The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests.
Largent EA, Wexler A, Karlawish J. Largent EA, et al. JAMA Neurol. 2021 Apr 1;78(4):379-380. doi: 10.1001/jamaneurol.2020.4835. JAMA Neurol. 2021. PMID: 33393982 Free PMC article. Review. No abstract available.
Rapid Progress Toward Reliable Blood Tests for Alzheimer Disease.
Thijssen EH, Rabinovici GD. Thijssen EH, et al. JAMA Neurol. 2021 Feb 1;78(2):143-145. doi: 10.1001/jamaneurol.2020.4200. JAMA Neurol. 2021. PMID: 33165524 No abstract available.
[Asialo GM1].
Tanaka M. Tanaka M. Nihon Rinsho. 2004 Dec;62 Suppl 12:797-9. Nihon Rinsho. 2004. PMID: 15658453 Review. Japanese. No abstract available.